Buget's R&D investment increase must propel action on AMR, says Dr Peter Jackson of Infex Therapeutics
Commenting in reaction to the Chancellor’s budget on 27th October 20201, Dr Peter Jackson, executive director, Infex Therapeutics, said:
“The announcement…